Page 2 - Indian Drug Makers

Govt engaging with drug makers to ramp up production of anti-fungal drug

The government is engaging with the drug manufacturers to ramp up the production of an antifungal drug used for the treatment of mucormycosis, says Chemicals and Fertilizers Ministry

Govt asks drug makers to ramp up remdesivir production to full capacity

The government on Wednesday said that all seven manufacturers of remdesivir in the country have been asked to ramp up production to full capacity by next week.

A bitter pill: Domestic pharma market growth slides to 1.1% in February

Recovery slow, top drug firms post muted growth in February

Indian drug makers gear up to make Gilead's remdesivir for Covid-19 therapy

Domestic players will be free to price it; Dutch firm Mylan also to make the drug in India; no royalty for Gilead as yet

Coronavirus outbreak: Quick USFDA approvals for asthma drug makers

Cipla gets nod for drug from USFDA earlier than expected; Lupin in fray

Govt approves Rs 13K-crore package to boost bulk drugs manufacture

Industry feels India first needs to tap existing capacity before setting up new drugs parks

Firms fear coronavirus outbreak in China may hit India's drug industry

The Department of Pharmaceuticals (DoP) last week constituted a high-level panel to assess its impact of the outbreak of the deadly virus in China on the supply of APIs in India

Indian drug makers take a hit on quality compliance, R&D investments

The trend is unlikely to reverse in the near term, say experts

Best of BS Opinion: The antibiotics challenge, warship woes, and more

Is size an advantage for pursuing the objectives of public sector banking? What is the role of India's financial sector in achieving the $5-trillion economy target? Alokananda Chakraborty sums up.

US margins under stress, Indian drug makers get booster dose in Europe

Respiratory solutions and cancer drugs are the biggest growth drivers for several companies in the Continent